Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Duanbo Shi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Annals of Surgical Oncology|February 16, 2023
Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-AnalysisSong Li, Qian Xu, Xin Dai, et al.
Medical Image Analysis|January 22, 2025
When multiple instance learning meets foundation models: Advancing histological whole slide image analysisHongming Xu, Mingkang Wang, Duanbo Shi, et al.
Journal of Cancer|March 24, 2020
CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFRYiting Sun, Song Li, Wenbin Yu, et al.
Scientific Reports|October 31, 2025
An automatic severity grading system using confocal laser endomicroscopy to evaluate inflammatory activity of ulcerative colitis: a prospective studyPeiting Xue, Jing Guo, Zhilong Che, et al.
Frontiers in Immunology|January 29, 2026
Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancerSong Li, Qian Xu, Wenbin Yu, et al.
Nature Communications|January 3, 2023
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancerSong Li, Wenbin Yu, Fei Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II TrialSong Li, Zimin Liu, Yanguo Liu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Annals of Surgical Oncology|February 16, 2023
Neoadjuvant Therapy with Immune Checkpoint Inhibitors in Gastric Cancer: A Systematic Review and Meta-AnalysisSong Li, Qian Xu, Xin Dai, et al.
Medical Image Analysis|January 22, 2025
When multiple instance learning meets foundation models: Advancing histological whole slide image analysisHongming Xu, Mingkang Wang, Duanbo Shi, et al.
Journal of Cancer|March 24, 2020
CD148 Serves as a Prognostic Marker of Gastric Cancer and Hinders Tumor Progression by Dephosphorylating EGFRYiting Sun, Song Li, Wenbin Yu, et al.
Scientific Reports|October 31, 2025
An automatic severity grading system using confocal laser endomicroscopy to evaluate inflammatory activity of ulcerative colitis: a prospective studyPeiting Xue, Jing Guo, Zhilong Che, et al.
Frontiers in Immunology|January 29, 2026
Survival and multi-omics analysis of immunotherapy-based conversion treatment for initially unresectable gastric cancerSong Li, Qian Xu, Wenbin Yu, et al.
Nature Communications|January 3, 2023
Neoadjuvant therapy with immune checkpoint blockade, antiangiogenesis, and chemotherapy for locally advanced gastric cancerSong Li, Wenbin Yu, Fei Xie, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 26, 2026
First-Line Disitamab Vedotin, Tislelizumab, and S-1 in HER2-Overexpressing Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: A Single-Arm, Phase II TrialSong Li, Zimin Liu, Yanguo Liu, et al.
Pageof 1